SlideShare a Scribd company logo
Journal Club
AFREEN NASIR
PharmD intern
Acharya & BM Reddy College of Pharmacy
Bengaluru
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 1
Drug Utilization Pattern in Adult Medical Intensive Care Unit of a Tertiary
Care Hospital
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 2
Thomas A, Adake U, Sharma A, Raut A
Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune,
Maharashtra, India
• Published in Journal : CHRISMED Journal of Health and Research.
• Year : Jan-Mar 2019| Volume : 6 | Issue : 1 | Page No. : 35-38.
• DOI: 10.4103/cjhr.cjhr_45_18
ABOUT THE JOURNAL
• It is a publication of Christian Medical College, Ludhiana Society.
• It is a peer-reviewed Quarterly Journal with both online and print versions.
• It is an Open Access journal.
• It does not charge for submission, processing or publication of manuscripts.
• It covers technical and clinical studies related to health, ethical and social issues in field of Medical, Nursing, Dental,
Allied Health.
• The journal is indexed with DOAJ, Index Copernicus.
• Abbreviation: CHRISMED J Health Res.
Impact Factor h - index Publisher Country ISSN
0.1 6 Medknow, part of Wolters Kluwer Health India 2348-3334, 2348-506X
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 3
Abstract :
Aim: To evaluate the drug utilization pattern in terms of Defined Daily Dose (DDD) in adult Medical Intensive Care
Unit.
Methodology: In this prospective study conducted over a period of 8 months, data pertaining to all adult (age ≥18
years) patients’ demography, diagnosis, treatment, and laboratory investigation were collected. The drugs were
categorized by anatomical therapeutic classification, and their DDD was calculated.
Result: A total of 452 patients were evaluated, of which 62.6% were males. The most common reason for
hospitalization was cardiovascular disorder (21.4%). An average of 9.9 drugs was prescribed per patient. Nearly 52%
of drugs were administered parenteral, 43% were oral. The most common drugs prescribed were pantoprazole,
ondansetron, aspirin and most common antimicrobials were ceftriaxone followed by piperacillin + tazobactam and
metronidazole.
Conclusion: Drug utilization produces an important impact on quantitative data for ICU patients and should be
conducted regularly so as to understand the drug consumption as well as for protocol implementation to improve the
quality of health care.
Keyword: Defined Daily Dose, Prospective study, Anatomical therapeutic Chemical classification system.
Introduction:
• WHO defines Drug Utilization Evaluation as “marketing, distribution, prescription, and use of drugs in a society,
with special emphasis on the resulting medical, social, and economic consequences”.
• It provide insights into different aspects of drug use.
• Defined Daily Dose (DDD) is the assumed average maintenance dose per day for a drug used for its main
indication in adults.
Objectives:
• To understand the pattern of drug use and evaluating the drug utilization pattern in terms of DDD in adult medical
ICU (MICU).
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 4
Methods:
• Study site: 15-bedded adult medical intensive care unit of Tertiary care hospital, Pune, Maharashtra, India.
• Study design: Prospective study
• Study duration: 8 months ( Aug 2016-Mar 2017)
• Inclusion criteria: Patients above 18 years admitted in MICU of Tertiary care hospital, Pune, Maharashtra, India.
• Sample size: 452 adult patients were admitted in 15-bedded MICU during the study period.
• Data collection: Modified patient profile form was developed to collect demographic, diagnosis, treatment, lab
investigation details.
• Data management:
 Data obtained were assessed for the age and gender distribution, reason for hospitalization, total number of drugs,
drug class, indication, dose, and route of administration.
 The drugs were classified based on ATC and DDD was calculated.
 DDD/100 bed days was calculated using the formula:
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 5
Results:
Distribution of patients based on gender
Age distribution: Mean age of patients was 57
146 (32%) of total patients were above 65 years.
Reasons for admission
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 6
Gender No. of patients %
Male 283 62.6
Female 169 37.3
Diseases No. of
patients
%
CVD 97 21.4
Respiratory
disorder
95 21
CNS disorder 94 20
Results:
Distribution of patients based on comorbidities
Distribution of patients based on route of administration
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 7
Comorbidities No. of patients
HTN 181
Diabetes mellitus 128
Ischemic heart disease 85
CKD 39
COPD 21
Route of administration No. of drugs
Parenteral 2329
Oral 1913
Nebulization or topical 225
• Average length of stay per patient
was 4.8 days.
• A total of 4467 medication were
prescribed during the study
period in ICU.
• An average of 9.9 drugs was
prescribed per patient.
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 8
Results:
ATC classification FDC
• Of total prescribed drugs, 268 (6%)
was given as fixed drug
combination (FDC).
• The commonly prescribed FDCs
were piperacillin-tazobactam (80)
followed by ipratropium
bromide/levosalbutamol (71) and
amoxicillin-clavulanic acid (15).
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 9
Results:
DDD/100 bed days
Drugs DDD/100 bed days
Pantoprazole 25.7
Paracetamol 25
Atrovastatin 22.9
Ondansetron 21.2
Furosemide 20.2
Ceftriaxone 26
Metronidazole 15.7
Piptaz 12.2
Azithromycin 10
Meropenem 4.18
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 10
Discussion
• This study observed that male were admitted more compared to female which was similar to study done by Patel et al.
• In this study common comorbid conditions were HTN (40%) & diabetes mellitus (28%) which was similar to study
done by Kaur et al., which provided evidence to existing increasing status of those condition as burden of
developing and developed countries.
• The average length of stay of patient was 4.8 days which was similar to Patel et al. Prolonged stay in the
ICU increases the overall costs & consumes more resources, increases the risk of ADR. Therefore, early
discharge from ICU plays a major role in minimizing economic burden.
• Study done by Patanaik et al., Balaji et al. also documented that drugs were commonly administered
through parenteral & oral routes. Since patients admitted in ICU require rapid therapeutic intervention,
parenteral dose can provide immediate onset of action.
• Study done by Balaji et al. & Patanaik SK et al. also documented that Pantoprazole was commonly prescribed drug in
ICU because it suppresses gastric acid secretion, prevents upper GI bleeding and promotes mucosal healing.
 Study by Mohebbi L et al. observed that between 75% and 100% of ICU patients had stress-related mucosal disease
within 24 hr of admission, as a result administration of acid suppression therapy for stress ulcer prophylaxis in the ICU
was well recommended to prevent GI bleeding.
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 11
Discussion
• In this study use of anti-infective as prophylaxis was a higher accounting (14%) of total drugs prescribed. It had
been documented by Dasgupta et al. that the incidence of nosocomial infection in ICU was about 2–5 times
higher than in the general inpatient hospital population.
Mythri et al. study observed that 17.7% incidence of nosocomial infection could be seen in MICU patients
which could lead to increase number of anti infective prescription.
• Of total drugs prescribed, only 6% were FDC. Shah et al. had documented about 70.83% of FDC
prescription. In this study, there were minimal use of FDCs reflecting the rational use of drugs.
• This study observed that DDD of pantoprazole and furosemide was 25.7 and 20.2 DDD/100 bed-days, which
was less than a study reporting 48.9 and 23.7 DDD/100 bed-days. DDD of ceftriaxone was 26 DDD/100
bed-days which was more compared to study done by Patanaik et al. which was 23.7 DDD/100 bed-days
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 12
Limitations
• Ethical approval details were not mentioned.
• There were no exclusion criteria.
• Interpretation of DDD was not done.
Limitations mentioned in the article:
• The data pertaining to their study couldn’t be generalizable to critical care units with a substantial different
means of the severity of illness or markedly different patient types such as surgical, neurological ICUs,
nonteaching hospital.
• They had not assessed the cost of drug therapy which would have helped to understand the financial burden of
ICU patients.
THANK YOU
Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 13

More Related Content

Similar to Journal club on Drug Utilization Pattern in ICU

Article 1527760801
Article 1527760801 Article 1527760801
Article 1527760801
vallampati prudhvi
 
Proton pump inhibitor drug assesment ppt
Proton pump inhibitor drug assesment pptProton pump inhibitor drug assesment ppt
Proton pump inhibitor drug assesment ppt
PavithraG56
 
Drug formulary INDIA
Drug formulary INDIADrug formulary INDIA
Drug formulary INDIA
Mohammed Yaser Hussain
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
ABUBAKRANSARI2
 
Drug use pattern in health care centers of District Bhakkar, Pakistan
Drug use pattern in health care centers of District Bhakkar, PakistanDrug use pattern in health care centers of District Bhakkar, Pakistan
Drug use pattern in health care centers of District Bhakkar, Pakistan
Open Access Research Paper
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
ashfaq22
 
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OFTHE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
Islam Shallal
 
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Health Innovation Wessex
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
GauravAdhikari23
 
An overview of deprescribing
An overview of deprescribingAn overview of deprescribing
An overview of deprescribing
saintaustyno
 
Patient compliance challenges in management of cardiac diseases in kuala lump...
Patient compliance challenges in management of cardiac diseases in kuala lump...Patient compliance challenges in management of cardiac diseases in kuala lump...
Patient compliance challenges in management of cardiac diseases in kuala lump...
pharmaindexing
 
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
pharmaindexing
 
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
MatiaAhmed
 
DOC-20160815-WA0002
DOC-20160815-WA0002DOC-20160815-WA0002
DOC-20160815-WA0002
abdifitah mahamoud muufo
 
Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.
Dr. Sharad Chand
 
Adr project
Adr projectAdr project
Adr project
Anusha Rameshwaram
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATION
KAVIYA AP
 
Patterns Poster
Patterns PosterPatterns Poster
Patterns Poster
Lavin Aliasgharlu
 
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
M.Arumuga Vignesh
 
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
ANURAG GROUP OF INSTITUTIONS
 

Similar to Journal club on Drug Utilization Pattern in ICU (20)

Article 1527760801
Article 1527760801 Article 1527760801
Article 1527760801
 
Proton pump inhibitor drug assesment ppt
Proton pump inhibitor drug assesment pptProton pump inhibitor drug assesment ppt
Proton pump inhibitor drug assesment ppt
 
Drug formulary INDIA
Drug formulary INDIADrug formulary INDIA
Drug formulary INDIA
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Drug use pattern in health care centers of District Bhakkar, Pakistan
Drug use pattern in health care centers of District Bhakkar, PakistanDrug use pattern in health care centers of District Bhakkar, Pakistan
Drug use pattern in health care centers of District Bhakkar, Pakistan
 
Drug_Utilization_Review.ppt
Drug_Utilization_Review.pptDrug_Utilization_Review.ppt
Drug_Utilization_Review.ppt
 
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OFTHE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
THE IMPACT OF CLINICAL PHARMACIST IN DETECTION OF
 
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
An overview of deprescribing
An overview of deprescribingAn overview of deprescribing
An overview of deprescribing
 
Patient compliance challenges in management of cardiac diseases in kuala lump...
Patient compliance challenges in management of cardiac diseases in kuala lump...Patient compliance challenges in management of cardiac diseases in kuala lump...
Patient compliance challenges in management of cardiac diseases in kuala lump...
 
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
Patient compliance: Challenges in management of cardiac diseases in Kuala Lum...
 
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
Pprescribing practice-of-antibiotics-for-outpatients-in-bangladesh-rationalit...
 
DOC-20160815-WA0002
DOC-20160815-WA0002DOC-20160815-WA0002
DOC-20160815-WA0002
 
Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.Journal club -pharmacist intervention in cost saving.
Journal club -pharmacist intervention in cost saving.
 
Adr project
Adr projectAdr project
Adr project
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATION
 
Patterns Poster
Patterns PosterPatterns Poster
Patterns Poster
 
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
Research on ADR in in-patients using Naronji's and who scale: A basic necessi...
 

More from Dr. Afreen Nasir

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
Dr. Afreen Nasir
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
Dr. Afreen Nasir
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
Dr. Afreen Nasir
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Dr. Afreen Nasir
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
Dr. Afreen Nasir
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
Dr. Afreen Nasir
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
Dr. Afreen Nasir
 
Case Presentation: decompensated liver disease secondary to alcohol with coag...
Case Presentation: decompensated liver disease secondary to alcohol with coag...Case Presentation: decompensated liver disease secondary to alcohol with coag...
Case Presentation: decompensated liver disease secondary to alcohol with coag...
Dr. Afreen Nasir
 
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Dr. Afreen Nasir
 
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
Dr. Afreen Nasir
 
Case Presentation: Cryptococcal meningitis
Case Presentation:  Cryptococcal meningitisCase Presentation:  Cryptococcal meningitis
Case Presentation: Cryptococcal meningitis
Dr. Afreen Nasir
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
Dr. Afreen Nasir
 
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Dr. Afreen Nasir
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
Dr. Afreen Nasir
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
Dr. Afreen Nasir
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
Dr. Afreen Nasir
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
Dr. Afreen Nasir
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
Dr. Afreen Nasir
 

More from Dr. Afreen Nasir (20)

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
 
Case Presentation: decompensated liver disease secondary to alcohol with coag...
Case Presentation: decompensated liver disease secondary to alcohol with coag...Case Presentation: decompensated liver disease secondary to alcohol with coag...
Case Presentation: decompensated liver disease secondary to alcohol with coag...
 
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
Case Presentation: Severe microcytic hypochromic iron deficiency anemia with ...
 
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( ne...
 
Case Presentation: Cryptococcal meningitis
Case Presentation:  Cryptococcal meningitisCase Presentation:  Cryptococcal meningitis
Case Presentation: Cryptococcal meningitis
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
 
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
Case Presentation: CRYPTOCOCCAL MENINGITIS & ORAL CANDIDIASIS –Opportunistic ...
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
 

Recently uploaded

DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
Lift Ability
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
Sheard's criterion and Percival criterion.pptx
Sheard's criterion and Percival criterion.pptxSheard's criterion and Percival criterion.pptx
Sheard's criterion and Percival criterion.pptx
National academy of medical science,Bir hospital
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
bkling
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
bkling
 
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
د حاتم البيطار
 

Recently uploaded (20)

DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
Sheard's criterion and Percival criterion.pptx
Sheard's criterion and Percival criterion.pptxSheard's criterion and Percival criterion.pptx
Sheard's criterion and Percival criterion.pptx
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdfMBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
 
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
 
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
 

Journal club on Drug Utilization Pattern in ICU

  • 1. Journal Club AFREEN NASIR PharmD intern Acharya & BM Reddy College of Pharmacy Bengaluru Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 1
  • 2. Drug Utilization Pattern in Adult Medical Intensive Care Unit of a Tertiary Care Hospital Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 2 Thomas A, Adake U, Sharma A, Raut A Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India • Published in Journal : CHRISMED Journal of Health and Research. • Year : Jan-Mar 2019| Volume : 6 | Issue : 1 | Page No. : 35-38. • DOI: 10.4103/cjhr.cjhr_45_18 ABOUT THE JOURNAL • It is a publication of Christian Medical College, Ludhiana Society. • It is a peer-reviewed Quarterly Journal with both online and print versions. • It is an Open Access journal. • It does not charge for submission, processing or publication of manuscripts. • It covers technical and clinical studies related to health, ethical and social issues in field of Medical, Nursing, Dental, Allied Health. • The journal is indexed with DOAJ, Index Copernicus. • Abbreviation: CHRISMED J Health Res. Impact Factor h - index Publisher Country ISSN 0.1 6 Medknow, part of Wolters Kluwer Health India 2348-3334, 2348-506X
  • 3. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 3 Abstract : Aim: To evaluate the drug utilization pattern in terms of Defined Daily Dose (DDD) in adult Medical Intensive Care Unit. Methodology: In this prospective study conducted over a period of 8 months, data pertaining to all adult (age ≥18 years) patients’ demography, diagnosis, treatment, and laboratory investigation were collected. The drugs were categorized by anatomical therapeutic classification, and their DDD was calculated. Result: A total of 452 patients were evaluated, of which 62.6% were males. The most common reason for hospitalization was cardiovascular disorder (21.4%). An average of 9.9 drugs was prescribed per patient. Nearly 52% of drugs were administered parenteral, 43% were oral. The most common drugs prescribed were pantoprazole, ondansetron, aspirin and most common antimicrobials were ceftriaxone followed by piperacillin + tazobactam and metronidazole. Conclusion: Drug utilization produces an important impact on quantitative data for ICU patients and should be conducted regularly so as to understand the drug consumption as well as for protocol implementation to improve the quality of health care. Keyword: Defined Daily Dose, Prospective study, Anatomical therapeutic Chemical classification system.
  • 4. Introduction: • WHO defines Drug Utilization Evaluation as “marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social, and economic consequences”. • It provide insights into different aspects of drug use. • Defined Daily Dose (DDD) is the assumed average maintenance dose per day for a drug used for its main indication in adults. Objectives: • To understand the pattern of drug use and evaluating the drug utilization pattern in terms of DDD in adult medical ICU (MICU). Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 4
  • 5. Methods: • Study site: 15-bedded adult medical intensive care unit of Tertiary care hospital, Pune, Maharashtra, India. • Study design: Prospective study • Study duration: 8 months ( Aug 2016-Mar 2017) • Inclusion criteria: Patients above 18 years admitted in MICU of Tertiary care hospital, Pune, Maharashtra, India. • Sample size: 452 adult patients were admitted in 15-bedded MICU during the study period. • Data collection: Modified patient profile form was developed to collect demographic, diagnosis, treatment, lab investigation details. • Data management:  Data obtained were assessed for the age and gender distribution, reason for hospitalization, total number of drugs, drug class, indication, dose, and route of administration.  The drugs were classified based on ATC and DDD was calculated.  DDD/100 bed days was calculated using the formula: Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 5
  • 6. Results: Distribution of patients based on gender Age distribution: Mean age of patients was 57 146 (32%) of total patients were above 65 years. Reasons for admission Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 6 Gender No. of patients % Male 283 62.6 Female 169 37.3 Diseases No. of patients % CVD 97 21.4 Respiratory disorder 95 21 CNS disorder 94 20
  • 7. Results: Distribution of patients based on comorbidities Distribution of patients based on route of administration Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 7 Comorbidities No. of patients HTN 181 Diabetes mellitus 128 Ischemic heart disease 85 CKD 39 COPD 21 Route of administration No. of drugs Parenteral 2329 Oral 1913 Nebulization or topical 225 • Average length of stay per patient was 4.8 days. • A total of 4467 medication were prescribed during the study period in ICU. • An average of 9.9 drugs was prescribed per patient.
  • 8. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 8 Results: ATC classification FDC • Of total prescribed drugs, 268 (6%) was given as fixed drug combination (FDC). • The commonly prescribed FDCs were piperacillin-tazobactam (80) followed by ipratropium bromide/levosalbutamol (71) and amoxicillin-clavulanic acid (15).
  • 9. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 9 Results: DDD/100 bed days Drugs DDD/100 bed days Pantoprazole 25.7 Paracetamol 25 Atrovastatin 22.9 Ondansetron 21.2 Furosemide 20.2 Ceftriaxone 26 Metronidazole 15.7 Piptaz 12.2 Azithromycin 10 Meropenem 4.18
  • 10. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 10 Discussion • This study observed that male were admitted more compared to female which was similar to study done by Patel et al. • In this study common comorbid conditions were HTN (40%) & diabetes mellitus (28%) which was similar to study done by Kaur et al., which provided evidence to existing increasing status of those condition as burden of developing and developed countries. • The average length of stay of patient was 4.8 days which was similar to Patel et al. Prolonged stay in the ICU increases the overall costs & consumes more resources, increases the risk of ADR. Therefore, early discharge from ICU plays a major role in minimizing economic burden. • Study done by Patanaik et al., Balaji et al. also documented that drugs were commonly administered through parenteral & oral routes. Since patients admitted in ICU require rapid therapeutic intervention, parenteral dose can provide immediate onset of action. • Study done by Balaji et al. & Patanaik SK et al. also documented that Pantoprazole was commonly prescribed drug in ICU because it suppresses gastric acid secretion, prevents upper GI bleeding and promotes mucosal healing.  Study by Mohebbi L et al. observed that between 75% and 100% of ICU patients had stress-related mucosal disease within 24 hr of admission, as a result administration of acid suppression therapy for stress ulcer prophylaxis in the ICU was well recommended to prevent GI bleeding.
  • 11. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 11 Discussion • In this study use of anti-infective as prophylaxis was a higher accounting (14%) of total drugs prescribed. It had been documented by Dasgupta et al. that the incidence of nosocomial infection in ICU was about 2–5 times higher than in the general inpatient hospital population. Mythri et al. study observed that 17.7% incidence of nosocomial infection could be seen in MICU patients which could lead to increase number of anti infective prescription. • Of total drugs prescribed, only 6% were FDC. Shah et al. had documented about 70.83% of FDC prescription. In this study, there were minimal use of FDCs reflecting the rational use of drugs. • This study observed that DDD of pantoprazole and furosemide was 25.7 and 20.2 DDD/100 bed-days, which was less than a study reporting 48.9 and 23.7 DDD/100 bed-days. DDD of ceftriaxone was 26 DDD/100 bed-days which was more compared to study done by Patanaik et al. which was 23.7 DDD/100 bed-days
  • 12. Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 12 Limitations • Ethical approval details were not mentioned. • There were no exclusion criteria. • Interpretation of DDD was not done. Limitations mentioned in the article: • The data pertaining to their study couldn’t be generalizable to critical care units with a substantial different means of the severity of illness or markedly different patient types such as surgical, neurological ICUs, nonteaching hospital. • They had not assessed the cost of drug therapy which would have helped to understand the financial burden of ICU patients.
  • 13. THANK YOU Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy 13